TickerStat.com

Braveheart Bio, Inc. (BRVE)

Price—Loading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

No reported data

Total cash / debt

CashTotal debt

Financial statements

1 annual periodsNewest to oldest
2025
Research & development$1.5M
Operating income−$66.7M
Net income−$66.1M
Diluted EPSper diluted share-$17.20
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗